256 related articles for article (PubMed ID: 15377478)
1. Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.
Galli M; Elice F; Crippa C; Comotti B; Rodeghiero F; Barbui T
Haematologica; 2004 Sep; 89(9):1141-2. PubMed ID: 15377478
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide and thrombosis in patients with multiple myeloma.
Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M
Haematologica; 2001 Oct; 86(10):1108-9. PubMed ID: 11602422
[No Abstract] [Full Text] [Related]
3. Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myeloma: a single-center case series and review of the literature.
Martin MG; Vij R
Clin Lymphoma Myeloma; 2009 Aug; 9(4):320-3. PubMed ID: 19717384
[TBL] [Abstract][Full Text] [Related]
4. Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin.
Chennuru S; Baumann MA
Intern Med J; 2007 Jul; 37(7):506-7. PubMed ID: 17547733
[No Abstract] [Full Text] [Related]
5. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin.
Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M
Eur J Haematol; 2010 Jun; 84(6):484-92. PubMed ID: 20192986
[TBL] [Abstract][Full Text] [Related]
7. Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
Zangari M; Barlogie B; Anaissie E; Saghafifar F; Eddlemon P; Jacobson J; Lee CK; Thertulien R; Talamo G; Thomas T; Van Rhee F; Fassas A; Fink L; Tricot G
Br J Haematol; 2004 Sep; 126(5):715-21. PubMed ID: 15327525
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
Anaissie EJ; Coleman EA; Goodwin JA; Kennedy RL; Lockhart KD; Stewart CB; Coon SK; Bailey C; Barlogie B
Cancer; 2012 Jan; 118(2):549-57. PubMed ID: 21720994
[TBL] [Abstract][Full Text] [Related]
9. Update of thrombosis in multiple myeloma.
Leebeek FW
Thromb Res; 2016 Apr; 140 Suppl 1():S76-80. PubMed ID: 27067983
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide and thrombosis. A meta-analysis.
El Accaoui RN; Shamseddeen WA; Taher AT
Thromb Haemost; 2007 Jun; 97(6):1031-6. PubMed ID: 17549307
[TBL] [Abstract][Full Text] [Related]
11. [Brief report: stroke in multiple myeloma patient treated with thalidomide].
Ito Y; Mori A; Yonemura K; Hashimoto Y; Hirano T; Uchino M
Rinsho Shinkeigaku; 2007 Sep; 47(9):593-6. PubMed ID: 18018619
[TBL] [Abstract][Full Text] [Related]
12. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma.
Palumbo A; Rajkumar SV; Dimopoulos MA; Richardson PG; San Miguel J; Barlogie B; Harousseau J; Zonder JA; Cavo M; Zangari M; Attal M; Belch A; Knop S; Joshua D; Sezer O; Ludwig H; Vesole D; Bladé J; Kyle R; Westin J; Weber D; Bringhen S; Niesvizky R; Waage A; von Lilienfeld-Toal M; Lonial S; Morgan GJ; Orlowski RZ; Shimizu K; Anderson KC; Boccadoro M; Durie BG; Sonneveld P; Hussein MA;
Leukemia; 2008 Feb; 22(2):414-23. PubMed ID: 18094721
[TBL] [Abstract][Full Text] [Related]
13. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
[TBL] [Abstract][Full Text] [Related]
14. Lenalidomide and venous thrombosis in multiple myeloma.
Knight R; DeLap RJ; Zeldis JB
N Engl J Med; 2006 May; 354(19):2079-80. PubMed ID: 16687729
[No Abstract] [Full Text] [Related]
15. Cerebral venous thrombosis in an individual with multiple myeloma treated with lenalidomide.
Eudo C; Petit A; Mondon K; Rippault H; Dardaine V; Constans T; Hommet C; Cottier JP
J Am Geriatr Soc; 2011 Dec; 59(12):2371-2. PubMed ID: 22188080
[No Abstract] [Full Text] [Related]
16. Efficacy of prophylactic warfarin for prevention of thalidomide-related deep venous thrombosis.
Ikhlaque N; Seshadri V; Kathula S; Baumann MA
Am J Hematol; 2006 Jun; 81(6):420-2. PubMed ID: 16680743
[TBL] [Abstract][Full Text] [Related]
17. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
[TBL] [Abstract][Full Text] [Related]
18. The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.
Baz R; Li L; Kottke-Marchant K; Srkalovic G; McGowan B; Yiannaki E; Karam MA; Faiman B; Jawde RA; Andresen S; Zeldis J; Hussein MA
Mayo Clin Proc; 2005 Dec; 80(12):1568-74. PubMed ID: 16342649
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates.
Gieseler F
Thromb Haemost; 2008 Jun; 99(6):1001-7. PubMed ID: 18521500
[TBL] [Abstract][Full Text] [Related]
20. Deep venous thrombosis and thalidomide therapy for multiple myeloma.
Osman K; Comenzo R; Rajkumar SV
N Engl J Med; 2001 Jun; 344(25):1951-2. PubMed ID: 11419443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
